SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artículo

UNDABEITIA, J. et al. Clinical and economic analysis of hospital acquired infections in patients diagnosed with brain tumor in a tertiary hospital. NeurocirugĂ­a [online]. 2011, vol.22, n.6, pp.535-541. ISSN 1130-1473.

    1. Anderson, D.J., et al.: Underresourced hospital infection control and prevention programs: penny wise, pound foolish? Infect Control Hosp Epidemiol 2007; 28: 767-773. [ Links ]

    2. Barnholtz-Sloan, J.S., et al.: Patterns of care and outcomes among elderly individuals with primary malignant astrocytoma. J Neurosurg 2008; 108: 642-648. [ Links ]

    3. Blomqvist, P., et al.: Brain tumours in Sweden 1996: care and costs. J Neurol Neurosurg Psychiatry 2000; 69: 792-798. [ Links ]

    4. Burgmann, H., et al.: Impact of nosocomial infections on clinical outcome and resource consumption in critically ill patients. Intensive Care Med 2010; 36: 1597-1601. [ Links ]

    5. Burke, J.P.: Infection control -a problem for patient safety. N Engl J Med 2003; 348: 651-656. [ Links ]

    6. Byrne, D.J., et al.: Wound infection rates: the importance of definition and post-discharge wound surveillance. J Hosp Infect 1994; 26: 37-43. [ Links ]

    7. Chaichana, K.L., et al.: Supratentorial glioblastoma multiforme: the role of surgical resection versus biopsy among older patients. Ann Surg Oncol 2011; 18: 239-245. [ Links ]

    8. Chen, Y.Y., Chou, Y.C., Chou, P.: Impact of nosocomial infection on cost of illness and length of stay in intensive care units. Infect Control Hosp Epidemiol 2005; 26: 281-287. [ Links ]

    9. Cohen, D.R.: Economic issues in infection control. J Hosp Infect 1984; 5 Suppl A: 17-25. [ Links ]

    10. Drummond, M.F., Davies L.M.; Evaluation of the costs and benefits of reducing hospital infection. J Hosp Infect 1991; 18 Suppl A: 85-93. [ Links ]

    11. Dulworth, S., Pyenson, B.; Healthcare-associated infections and length of hospital stay in the Medicare population. Am J Med Qual 2004; 19: 121-127. [ Links ]

    12. Ekman, M., Westphal, M.: Cost of brain tumour in Europe. Eur J Neurol 2005; 12 Suppl 1: 45-49. [ Links ]

    13. Graves, N., et al.: Estimating the cost of health careassociated infections: mind your p's and q's. Clin Infect Dis 2010; 50: 1017-1021. [ Links ]

    14. Graves, N.; Economics and preventing hospital-acquired infection. Emerg Infect Dis 2004; 10: 561-566. [ Links ]

    15. Grossman, R., et al.: Predictors of inpatient death and complications among postoperative elderly patients with metastatic brain tumors. Ann Surg Oncol 2011; 18:521-528. [ Links ]

    16. Horan, T.C., Andrus, M., Dudeck, M.A.: CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36: 309-332. [ Links ]

    17. Kilgore, M.L., et al.: The costs of nosocomial infections. Med Care 2008; 46:101-104. [ Links ]

    18. Kirkland, K.B., et al.: The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999; 20: 725-730. [ Links ]

    19. Lagoe, R.J., Westert, G.P.: Evaluation of hospital inpatient complications: a planning approach. BMC Health Serv Res 2010; 10: 200. [ Links ]

    20. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32: 470-485. [ Links ]

    21. Olaechea, P.M., et al.: Epidemiology and impact of nosocomial infections. Med Intensiva 2010; 34: 256-267. [ Links ]

    22. Olaechea, P.M., et al.: Factors related to hospital stay among patients with nosocomial infection acquired in the intensive care unit. Infect Control Hosp Epidemiol 2003; 24: 207-213. [ Links ]

    23. Orsi, G.B., et al.: Hospital-acquired infection surveillance in a neurosurgical intensive care unit. J Hosp Infect 2006; 64: 23-29. [ Links ]

    24. Peng, M.M., Kurtz, S., Johannes, R.S.: Adverse outcomes from hospital-acquired infection in Pennsylvania cannot be attributed to increased risk on admission. Am J Med Qual 2006; 21: 17S-28S. [ Links ]

    25. Perencevich, E.N., et al.: Raising standards while watching the bottom line: making a business case for infection control. Infect Control Hosp Epidemiol 2007; 28: 1121-1133. [ Links ]

    26. Plowman, R., et al.: The rate and cost of hospitalacquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. J Hosp Infect 2001; 47: 198-209. [ Links ]

    27. Roberts, R.R., et al.: Costs attributable to healthcareacquired infection in hospitalized adults and a comparison of economic methods. Med Care 2010; 48: 1026-1035. [ Links ]

    28. Safdar, N., et al.: Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005; 33: 2184-2193. [ Links ]

    29. Saint, S., Chenoweth, C., Fendrick, A.M.: The role of economic evaluation in infection control. Am J Infect Control 2001; 29: 338-344. [ Links ]

    31. Scheckler, W.E., et al.: Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: a consensus panel report. Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol 1998; 19: 114-124. [ Links ]

    32. Stone, P.W., Braccia, D., Larson, E.: Systematic review of economic analyses of health care-associated infections. Am J Infect Control 2005; 33: 501-509. [ Links ]

    33. Stone, P.W., Kunches, L., Hirschhorn, L.: Cost of hospital-associated infections in Massachusetts. Am J Infect Control 2009; 37: 210-214. [ Links ]

    34. Stone, P.W.: Economic burden of healthcare-associated infections: an American perspective. Expert Rev Pharmacoecon Outcomes Res 2009; 9: 417-422. [ Links ]

    35. Weinstein, R.A.: Nosocomial infection update. Emerg Infect Dis 1998; 4: 416-420. [ Links ]

    36. Ylipalosaari, P., et al.: Intensive care acquired infection is an independent risk factor for hospital mortality: a prospective cohort study. Crit Care 2006; 10: R66. [ Links ]